Highlights
A collection of news and information related to Lilly Eli & Co published by this site and its partners.
Displaying items 1-12 of 205
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
10
11-18
•
Next >
-
ANALYSIS-Amazon gets help to lure big business to the cloud
Reuters(Repeats with no changes to text or headline) * Amazon has built up network of more than 4,000 cloud partners * Partners help satisfy more demanding enterprise customers * Crucial as Amazon targets $300 billion market By Alistair Barr SAN FRANCISCO,...Tags: E-Commerce Industry, Computing and Information Technology Industry, Oracle Corp., Adobe Systems Inc., Google Inc.
-
Analysis: Amazon gets help to lure big business to the cloud
ReutersSAN FRANCISCO (Reuters) - As Amazon.com Inc seeks to transform itself into a leading provider of technology to the world's largest corporations, it's discovering that it needs help. The online retailer, which since 2006 has moved aggressively into the...Tags: E-Commerce Industry, Computing and Information Technology Industry, Oracle Corp., Adobe Systems Inc., Google Inc.
-
Lilly CEO recovering after repair to aorta
ReutersMay 14 (Reuters) - John Lechleiter, the longtime chief executive of Eli Lilly and Co, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday. "Dr. Lechleiter is recovering and will be closely monitored by...Tags: Economy, Business and Finance, Medical Procedures and Tests, Companies and Corporations, Corporate Officers
-
U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group
ReutersMay 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...Tags: Prices, Brooks Automation Incorporated, Spark Networks Plc, Energy Resources, Great Plains Energy Incorporated
-
Eli Lilly's lymphoma drug fails in late-stage trial
ReutersMay 10 (Reuters) - Eli Lilly and Co said it will stop developing its experimental cancer drug after a late-stage trial failed to show a statistically significant increase in patients' disease-free survival. The drug, enzastaurin, was being tested in...Tags: Chemotherapy, Lymphoma, Health Treatments, Cancer
-
REUTERS SUMMIT-Novo's long-term targets hinge on two drugs -CEO
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Danish group under pressure after U.S. Tresiba setback * CEO says obesity drug could keep profit goals on track * Novo expects liraglutide for obesity to...Tags: Body Mass Index, New Products, Marketing, Medical Research, Food and Drug Administration
-
Lilly CEO Lechleiter to undergo surgery for dilated aorta
ReutersMay 6 (Reuters) - Drug maker Eli Lilly and Co said Chief Executive John Lechleiter will undergo a surgery on May 13 to treat a dilated aorta but is expected to recover and return to work by this summer. Chief Financial Officer Derica Rice will serve as...Tags: Economy, Business and Finance, Companies and Corporations, Symptoms, Corporate Officers, Swelling
-
February 26, 2002: Bowen lends voice to look at Reagan
BREMEN -- Dr. Otis R. Bowen, who celebrates his 84th birthday today, is already a permanent fixture in his hometown of Bremen, but later this year, he'll also become a permanent fixture in the Ronald Reagan library and museum. As a former Indiana...Tags: University of Virginia, Ronald Reagan, Medical Procedures and Tests, Executive Branch, Indiana University
-
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters* Head of diabetes says eyeing broadest portfolio in industry * Aiming to win bigger slice of growing market * Lilly currently No.4 in $40 bln diabetes market * Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt...Tags: Januvia (drug), Denmark, Drug Trafficking, Pharmaceuticals, Merck & Company Incorporated
-
Eli Lilly amplía oferta en diabetes para reforzar presencia en mercado
ReutersPor Ludwig Burger y Frank Siebelt FRANCFORT (Reuters) - Eli Lilly, el cuarto fabricante mundial de medicamentos para la diabetes, buscará tener la variedad más amplia posible de fármacos antidiabéticos con el fin de ganar una mayor porción de ese...Tags: Merck & Company Incorporated, Byetta (drug), Januvia (drug), Bristol Myers Squibb Company, AstraZeneca Plc
-
Veeva Systems planning initial public offering - sources
ReutersBy Olivia Oran April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according to two people familiar with the...Tags: Novartis AG, Chemical Industry, Computing and Information Technology Industry, Science and Technology, AstraZeneca Plc
-
U.S. RESEARCH ROUNDUP: Apple, Boeing, Eli Lilly, P&G
ReutersApril 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Boeing and Eli Lilly, on Thursday. HIGHLIGHTS * Apple : Hilliard Lyons raises to buy from long-term buy -...Tags: Prices, The Medicines Company, Crown Castle International Corporation, S&T Bancorp Incorporated, Zynga Inc.
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 5, 2013
|Story| South Bend Tribune
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 25, 2013
|Story| Reuters
Original site for Lilly Eli & Co topic gallery.